Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight

作者：Nalluri Nikhil; Patel Nileshkumar^*; Saouma Samer; Anugu Viswajit Reddy; Anugula Dixitha; Asti Deepak; Mehta Varshil; Kumar Varun; Atti Varunsiri; Edla Sushruth; Grewal Rasleen K; Khan Hafiz M; Kanotra Ritesh; Maniatis Gregory; Kandov Ruben; Lafferty James C; Dyal Michael; Alfonso Carlos E; Cohen Mauricio G

来源：Expert Review of Medical Devices, 2017, 14(10): 789-804.

DOI：10.1080/17434440.2017.1374849

• Percutaneous coronary interventions: PCI
• mechanical circulatory support: MCS
• high-risk percutaneous coronary interventions: HRPCI
• cardiogenic shock: CS
• refractory cardiac arrest: RCA
• intra-aortic balloon pump: IABP
• percutaneous ventricular assist device: pVAD
• acute myocardial infarction with cardiogenic shock: AMICS

Introduction: Impella is a catheter-based micro-axial flow pump placed across the aortic valve, and it is currently the only percutaneous left ventricular assist device approved for high-risk percutaneous coronary intervention and cardiogenic shock.Areas Covered: Even though several studies have repeatedly demonstrated the excellent hemodynamic profile of Impella in high-risk settings, it remains underutilized. Here we aim to provide an up-to-date summary of the available literature on Impellas use in High risk settingsas well as the practical aspectsof its usage.Expert Commentary: Percutaneous coronary interventions in high rsk settings have always been challenging for a physician. Impella 2.5 and CP, have been proven safe, cost effective and feasible in High Risk Percutaneous coronary Interventions with an excellent hemodynamic profile.

• 出版日期2017